Studies from our laboratory confirmed that, in pancreatic cancer cells, intracellular cAMP upregulates MRP4 through an Epac2/Rap1-mediated mechanism, whereas extracellular cAMP inhibits MRP4 promoter activity by a MEK/ERK-mediated pathway26. The gene discussed is RAPGEF4; the disease is pancreatic neoplasm.